Skip to main content
Independent science journalism
We do not sell or supply peptides
Peptide
Science
Daily
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Search
⌘K
Subscribe
News
Research
Compounds
Trials
Regulatory
Safety
Trackers
Theme
Subscribe to the newsletter
We do not sell or supply peptides.
Home
Trials
NCT01171690
Clinical Trials · NCT01171690
Teriparatide for Postsurgical Hypoparathyroidism
Terminated
Phase 2
Teriparatide
(Prohibited)
Phase
Phase 2
Recruitment status
Terminated
Sponsor
Mayo Clinic
Enrollment
5
Start date
Nov 2010
Locations
1 site, United States
Primary endpoint
Hospital Length of Stay
View Teriparatide compound reference